Skip to main content
NCBI home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1988 Jun;54(6):1405–1408. doi: 10.1128/aem.54.6.1405-1408.1988

Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.

M W Eklund 1, F T Poysky 1, L M Mseitif 1, M S Strom 1
PMCID: PMC202669  PMID: 2843093

Abstract

A single 81-megadalton plasmid was previously isolated from each of six toxigenic strains of Clostridium botulinum type G (M. S. Strom, M. W. Eklund, and F. T. Poysky, Appl. Environ. Microbiol. 48:956-963, 1984). In this study, nontoxigenic derivatives isolated from each of the toxigenic strains following consecutive daily transfers in Trypticase (BBL Microbiology Systems, Cockeysville, Md.)-yeast extract-glucose broth at 44 degrees C simultaneously ceased to produce type G neurotoxin and to harbor the resident 81-megadalton plasmid. The nontoxigenic derivatives also ceased to produce bacteriocin and lost their immunity to the bacteriocin produced by the toxigenic strains. In contrast, all of the toxigenic isolates continued to carry the resident plasmid and to produce both bacteriocin and type G neurotoxin. This is the first evidence suggesting that the production of neurotoxin and bacteriocin by C. botulinum is mediated by a plasmid.

Full text

PDF
1405

Images in this article

1407Image
on p.1407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anastasio K. L., Soucheck J. A., Sugiyama H. Boticinogeny and actions of the bacteriocin. J Bacteriol. 1971 Jul;107(1):143–149. doi: 10.1128/jb.107.1.143-149.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L. M., Hatheway C. L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis. 1986 Aug;154(2):207–211. doi: 10.1093/infdis/154.2.207. [DOI] [PubMed] [Google Scholar]
  3. Ciccarelli A. S., Whaley D. N., McCroskey L. M., Gimenez D. F., Dowell V. R., Jr, Hatheway C. L. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin. Appl Environ Microbiol. 1977 Dec;34(6):843–848. doi: 10.1128/aem.34.6.843-848.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dezfulian M., Dowell V. R., Jr Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases. J Clin Microbiol. 1980 Jun;11(6):604–609. doi: 10.1128/jcm.11.6.604-609.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eklund M. W., Poysky F. T. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol. 1972 Jul;24(1):108–113. doi: 10.1128/am.24.1.108-113.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eklund M. W., Poysky F. T. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl Microbiol. 1974 Jan;27(1):251–258. doi: 10.1128/am.27.1.251-258.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eklund M. W., Poysky F. T., Meyers J. A., Pelroy G. A. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage. Science. 1974 Nov 1;186(4162):456–458. doi: 10.1126/science.186.4162.456. [DOI] [PubMed] [Google Scholar]
  8. Eklund M. W., Poysky F. T., Reed S. M. Bacteriophage and the toxigenicity of Clostridium botulinum type D. Nat New Biol. 1972 Jan 5;235(53):16–17. doi: 10.1038/newbio235016a0. [DOI] [PubMed] [Google Scholar]
  9. Eklund M. W., Poysky F. T., Reed S. M., Smith C. A. Bacteriophage and the toxigenicity of Clostridium botulinum type C. Science. 1971 Apr 30;172(3982):480–482. doi: 10.1126/science.172.3982.480. [DOI] [PubMed] [Google Scholar]
  10. Giménez D. F., Ciccarelli A. S. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig. 1970;215(2):221–224. [PubMed] [Google Scholar]
  11. Giménez D. F., Ciccarelli A. S. New strains of Clostridium botulinum subtype Af. Zentralbl Bakteriol Orig A. 1978 Apr;240(2):215–220. [PubMed] [Google Scholar]
  12. Giménez D. F. Clostridium botulinum subtype Ba. Zentralbl Bakteriol Mikrobiol Hyg A. 1984 May;257(1):68–72. [PubMed] [Google Scholar]
  13. Hall J. D., McCroskey L. M., Pincomb B. J., Hatheway C. L. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol. 1985 Apr;21(4):654–655. doi: 10.1128/jcm.21.4.654-655.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Inoue K., Iida H. Conversion of toxigenicity in Clostridium botulinum type C. Jpn J Microbiol. 1970 Jan;14(1):87–89. doi: 10.1111/j.1348-0421.1970.tb00495.x. [DOI] [PubMed] [Google Scholar]
  15. Inoue K., Iida H. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jpn J Med Sci Biol. 1971 Feb;24(1):53–56. [PubMed] [Google Scholar]
  16. Jansen B. C. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J Vet Res. 1971 Jun;38(2):93–98. [PubMed] [Google Scholar]
  17. Kautter D. A., Harmon S. M., Lynt R. K., Jr, Lilly T., Jr Antagonistic effect on Clostridium botulinum type E by organisms resembling it. Appl Microbiol. 1966 Jul;14(4):616–622. doi: 10.1128/am.14.4.616-622.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lewis G. E., Jr, Kulinski S. S., Reichard D. W., Metzger J. F. Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay. Appl Environ Microbiol. 1981 Dec;42(6):1018–1022. doi: 10.1128/aem.42.6.1018-1022.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. REEVES P. THE BACTERIOCINS. Bacteriol Rev. 1965 Mar;29:24–45. doi: 10.1128/br.29.1.24-45.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schiller J., Strom M., Groman N., Coyle M. Relationship between pNG2, an Emr plasmid in Corynebacterium diphtheriae, and plasmids in aerobic skin coryneforms. Antimicrob Agents Chemother. 1983 Dec;24(6):892–901. doi: 10.1128/aac.24.6.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Simpson L. L. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins. J Pharmacol Exp Ther. 1982 Dec;223(3):695–701. [PubMed] [Google Scholar]
  22. Sonnabend O., Sonnabend W., Heinzle R., Sigrist T., Dirnhofer R., Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis. 1981 Jan;143(1):22–27. doi: 10.1093/infdis/143.1.22. [DOI] [PubMed] [Google Scholar]
  23. Strom M. S., Eklund M. W., Poysky F. T. Plasmids in Clostridium botulinum and related Clostridium species. Appl Environ Microbiol. 1984 Nov;48(5):956–963. doi: 10.1128/aem.48.5.956-963.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weickert M. J., Chambliss G. H., Sugiyama H. Production of toxin by Clostridium botulinum type A strains cured by plasmids. Appl Environ Microbiol. 1986 Jan;51(1):52–56. doi: 10.1128/aem.51.1.52-56.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES